Literature DB >> 9882035

The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia.

P Moayyedi1, S Duffett, D Braunholtz, S Mason, I D Richards, A C Dowell, A T Axon.   

Abstract

BACKGROUND: There is currently no validated questionnaire that assesses both the presence and severity of dyspepsia. AIM: To develop the Leeds Dyspepsia Questionnaire (LDQ) as a measure of the presence and severity of dyspepsia, and to assess the validity, reliability and responsiveness of this instrument.
METHODS: Unselected patients attending either a hospital dyspepsia clinic or a general practice surgery were interviewed by a trained gastroenterologist or a general practitioner on the presence and severity of dyspepsia. This opinion was compared with the results of the nurse-administered LDQ. Test-retest reliability was assessed by the same research nurse re-administering the LDQ 4-7 days after the initial visit in a subgroup of hospital patients. In a further subgroup of patients one researcher interviewed the patients and a second researcher re-administered the LDQ within 30 min to evaluate inter-rater reliability. The responsiveness of the LDQ was measured by repeating it in patients with endoscopically proven peptic ulcer or oesophagitis 1 month after receiving appropriate therapy.
RESULTS: The LDQ was administered to 99 general practice and 215 hospital patients. In the GP population 41/98 (42%) had dyspepsia according to the GP and the LDQ had a sensitivity of 80% (95% CI: 65-91%) and a specificity of 79% (95% CI: 66-89%). The weighted kappa statistic for the agreement between the LDQ and the clinician for the severity of dyspepsia was 0.58 in the GP population and 0.49 in hospital patients. The kappa statistic for test-retest reliability was 0.83 in 107 patients. The LDQ had excellent inter-rater reliability with a kappa statistic of 0.90 in 42 patients. The median LDQ score fell from 22.5 (range 9-36) to 4.5 (range 0-27) in 12 patients 1 month after receiving appropriate therapy (Wilcoxon signed rank test, P < 0.0001).
CONCLUSION: The LDQ is a valid, reliable and responsive instrument for measuring the presence and severity of dyspepsia.

Entities:  

Mesh:

Year:  1998        PMID: 9882035     DOI: 10.1046/j.1365-2036.1998.00404.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  45 in total

1.  On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation.

Authors:  C B Terwee; F W Dekker; W M Wiersinga; M F Prummel; P M M Bossuyt
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

2.  Clinically significant endoscopic findings in a multi-ethnic population with uninvestigated dyspepsia.

Authors:  Sanjiv Mahadeva; Khean-Lee Goh
Journal:  Dig Dis Sci       Date:  2012-06-12       Impact factor: 3.199

3.  Cerebral mechanism of puncturing at He-Mu point combination for functional dyspepsia: study protocol for a randomized controlled parallel trial.

Authors:  Shuai Yin; Yuan Chen; Du Lei; Rui-Rui Sun; Ting-Ting Ma; Pei-Min Feng; Zhao-Xuan He; Xue-Ling Suo; Pei-Hong Ma; Yu-Zhu Qu; Ke Qiu; Miao-Miao Jing; Qi-Yong Gong; Fan-Rong Liang; Jiao Chen; Fang Zeng
Journal:  Neural Regen Res       Date:  2017-05       Impact factor: 5.135

4.  Gastrointestinal dysfunction in Parkinson's disease.

Authors:  Michal Lubomski; Ryan L Davis; Carolyn M Sue
Journal:  J Neurol       Date:  2020-01-27       Impact factor: 4.849

5.  Validation of Spanish language dyspepsia questionnaire.

Authors:  Jonathan Goldman; Donald F Conrad; Catherine Ley; David Halperin; Maria de la Luz Sanchez; Rosario Villacorta; Julie Parsonnet
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

6.  Rabeprazole combined with hydrotalcite is effective for patients with bile reflux gastritis after cholecystectomy.

Authors:  Huimin Chen; Xiaobo Li; Zhizheng Ge; Yunjie Gao; Xiaoyu Chen; Yun Cui
Journal:  Can J Gastroenterol       Date:  2010-03       Impact factor: 3.522

7.  Impact of Helicobacter pylori infection and microscopic duodenal histopathological changes on clinical symptoms of patients with functional dyspepsia.

Authors:  Seyed Amir Mirbagheri; Nasim Khajavirad; Nasser Rakhshani; Mohammad Reza Ostovaneh; Seyed Mahmood Eshagh Hoseini; Vahid Hoseini
Journal:  Dig Dis Sci       Date:  2011-11-12       Impact factor: 3.199

8.  Effect of clinician-patient communication on compliance with flupentixol-melitracen in functional dyspepsia patients.

Authors:  Xiu-Juan Yan; Wen-Ting Li; Xin Chen; Er-Man Wang; Qing Liu; Hong-Yi Qiu; Zhi-Jun Cao; Sheng-Liang Chen
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

9.  Translation and validation of the Nepean Dyspepsia Index for functional dyspepsia in China.

Authors:  Xiao-Ping Tian; Ying Li; Fan-Rong Liang; Guo-Jie Sun; Jie Yan; Xiao-Rong Chang; Ting-Ting Ma; Shu-Yuan Yu; Xu-Guang Yang
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

10.  The EQ-5D (Euroqol) is a valid generic instrument for measuring quality of life in patients with dyspepsia.

Authors:  Sanjiv Mahadeva; Hwee-Lin Wee; Khean-Lee Goh; Julian Thumboo
Journal:  BMC Gastroenterol       Date:  2009-03-12       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.